Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C, Genotype 1”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01467492
What this trial is testing

Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 121
Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Post-approval studies (Phase 4)Study completedNCT00910975
What this trial is testing

Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C, Genotype 1
Göteborg University 100
Testing effectiveness (Phase 2)Study completedNCT00980330
What this trial is testing

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 463
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Testing effectiveness (Phase 2)Study completedNCT00217139
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT01903954
What this trial is testing

Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 283
Testing effectiveness (Phase 2)UnknownNCT01335711
What this trial is testing

CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects

Who this might be right for
Chronic Hepatitis C
ChronTech Pharma AB 32
Testing effectiveness (Phase 2)Study completedNCT00446134
What this trial is testing

Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 278
Not applicableStudy completedNCT02581163
What this trial is testing

Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Who this might be right for
Chronic Hepatitis C, Genotype 1 or 4
AbbVie 314
Large-scale testing (Phase 3)Study completedNCT00265395
What this trial is testing

Extended Treatment With PEG-Intron® and Rebetol® in Patients With Genotype 1 Chronic Hepatitis C and Slow Virologic Response (Study P03685)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,428
Testing effectiveness (Phase 2)Study completedNCT01030432
What this trial is testing

Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 285
Testing effectiveness (Phase 2)Study completedNCT00517439
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 516
Not applicableStudy completedNCT02725866
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 216
Post-approval studies (Phase 4)Study completedNCT00680173
What this trial is testing

Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 30
Early research (Phase 1)Study completedNCT01818856
What this trial is testing

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Who this might be right for
Hepatitis C, ChronicHIV Infection
Hospitales Universitarios Virgen del Rocío 14
Not applicableStudy completedNCT03002818
What this trial is testing

Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)

Who this might be right for
Chronic Hepatitis C Virus (HCV)
AbbVie 41
Large-scale testing (Phase 3)Study completedNCT01579474
What this trial is testing

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Who this might be right for
Hepatitis C
Boehringer Ingelheim 131
Post-approval studies (Phase 4)Study completedNCT00192647
What this trial is testing

Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 896
Testing effectiveness (Phase 2)Study completedNCT02226549
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 47
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation